Article
Mdmx and Mdm2: Brothers in Arms?
1 Jul 2004
Abstract excerpt
The p53 tumor suppressor pathway is inactivated in most if not all human tumors. In about 50% of the cases this is accomplished directly by gene mutations. The tumors that retain wild type p53 frequently show defects either in effector target genes, or in the expression of p53 regulatory proteins. The Mdm2 protein is generally considered THE master regulator of the p53 tumor suppressor activity. Recently,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
